Visualitzant Centre d'Esclerosi Múltiple de Catalunya - CEMCAT per títol
Ara mostrant els elements 15-34 d 106
-
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement
(SAGE Publications, 2023-02) -
Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
(Lippincott Williams & Wilkins, 2021-01) -
Clinical use of dimethyl fumarate in multiple sclerosis treatment: an update to include China, using a modified Delphi method
(SAGE Publications, 2023-07-14) -
Cognitive assessment in patients with multiple sclerosis: A Spanish consensus
(Frontiers Media, 2022-12-20) -
Cognitive impairment in multiple sclerosis: diagnosis and monitoring
(Springer, 2021-12) -
Consensus on early detection of disease progression in patients with multiple sclerosis
(Frontiers Media, 2022-07-28) -
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
(Elsevier, 2022-10) -
CSF SERPINA3 Levels Are Elevated in Patients With Progressive MS
(Wolters Kluwer Health, 2021-03) -
Deciphering Multiple Sclerosis Progression
(Frontiers Media, 2021-04) -
Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report
(Frontiers Media, 2023-07-20) -
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging
(Lippincott, Williams & Wilkins, 2023-01-17)